Hétérocycles azotés (N)

Please enquire for more information about 2-Methyl-2-propanyl {(1R)-2-[5-bromo-3-(2,6-difluorobenzyl)-4-methyl-2,6-dioxo-3,6-dihydro-1(2H)-pyrimidinyl]-1-phenylethyl}carbamat e including the price, delivery time and more detailed product information at the technical inquiry form on this page

Applications 1-(oxan-4-yl)-1H-1,2,3-triazole-4-carboxylic acid (cas# 1487610-80-9) is a useful research chemical.

Please enquire for more information about [(1'-Methyl-1,4'-bipiperidin-4-yl)methyl]amine trihydrochloride including the price, delivery time and more detailed product information at the technical inquiry form on this page

3-Fluoropyridine 1-oxide is a fluorinated organic compound that can act as an aminating agent. It has been shown to react with 4-bromopyridine in the presence of fluoride to form 3,5-dibromopyridin-2(1H)-one 1,1-dioxide. The reaction product has also been found to be effective in the synthesis of perfluoropropene and carbonyl compounds. 3-Fluoropyridine 1-oxide interacts thermally with a variety of nucleophilic partners such as amines, alcohols, and thiols. This interaction energy is calculated using quantum chemical calculations.

Please enquire for more information about 4-({[4-(Azepan-1-ylmethyl)piperidin-1-yl]carbonyl}amino)benzoic acid hydrochloride including the price, delivery time and more detailed product information at the technical inquiry form on this page

1-(4-Ethoxycarbonylphenyl)piperazine is an enantiopure phosphatase inhibitor. It is used in the treatment of cancer and other life-threatening diseases. 1-(4-Ethoxycarbonylphenyl)piperazine inhibits phosphatases, which are enzymes that catalyze hydrolysis of phosphate groups from substrates. This inhibition leads to a decrease in the production of fatty acids and cholesterol, resulting in a reduction in body mass index. The drug has been shown to be effective against animal models for cancer, with an effective dose of 100 mg/kg intraperitoneally. In addition, 1-(4-ethoxycarbonylphenyl)piperazine has been shown to inhibit cardiac phosphatases and increase cardiac uptake by inhibiting acylation reactions.

This compound is an orally bioavailable, potent, selective and efficacious inhibitor of the enzyme acetylcholinesterase (AChE). It has been shown to cross the blood-brain barrier in mice and inhibit AChE activity in the brain. The compound shows efficacy in animal models of Alzheimer's disease with a potency and a selectivity that are superior to those of other known inhibitors. The drug also improves memory and learning performance in these animal models. In addition, it does not produce any signs of toxicity even at high doses.

1-(3-Sulphonatopropyl)-2-vinylpyridinium betaine is an initiator for polymers. It is a monomer that can be copolymerized with other monomers, such as styrene and acrylonitrile. Copolymerization of 1-(3-sulphonatopropyl)-2-vinylpyridinium betaine with styrene and acrylonitrile produces poly(styrene-co-acrylonitrile) (PSA). The polymerization process involves the release of sulphur dioxide gas from the initiator, which is then converted to sulphuric acid by atmospheric oxygen. This chemical reaction also produces heat that causes the temperature of the polymerization to increase. X-ray photoelectron spectroscopy (XPS) and x-ray diffraction (XRD) were used to characterize the chemical compositions of PSA. The nature of